Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
Become a Member | Sign in
Home>News>This Article

Lung Disease and Melanoma: a Common Molecular Mechanism?

Published: Monday, September 02, 2013
Last Updated: Monday, September 02, 2013
Bookmark and Share
Researchers have solved a biological mystery about the common genesis of many serious diseases such as asthma and metastatic melanoma.

Scientists have identified the first known pathway by which their cellular functions turn abnormal, and a healthy process goes haywire. The study is published in Cell Reports.

The team focused on an ancient gene family known as “18 glycosyl hydrolase (GH 18),” and in particular, one protein known as chitinase 3-like-1 (Chi3l1). This protein plays a critical role in the body’s response to foreign pathogens, augmenting the killing of bacteria while controlling inflammation and cell death to keep the immune response from harming normal tissue.

Although previous studies from this Yale team and colleagues have helped define the roles of Chi3l1 in biology, the mechanism by which it works — and triggers disease when overexpressed — was not known. The Yale team knew that Chi3l1 was not functioning as an enzyme would. They theorized that it acted, instead, by binding to a cellular receptor. Their studies led them to focus on a receptor known as IL-13Rα2, which was thought to be a so-called “decoy receptor” that binds molecules but does not induce cellular signaling or activate a biologic response.

Their experiments in mice proved that IL-13Rα2 was no decoy at all, but an active participant in the signaling pathway. The binding of overexpressed Chi3l1 and the receptor IL-13Rα2 began a cascade of subsequent reactions in the mice that resulted in lung disease, lung melanoma metastasis, and a host of other diseases.

“What we discovered was that when Chi3l1 is produced, IL-13Rα2 binds it and acts as a catalyst, triggering important biologic responses such as the control of cell death and production of inflammatory mediators,” said senior author Dr. Jack A. Elias, chair of internal medicine at Yale School of Medicine and a member of Yale Cancer Center.

Elias hopes that further research will identify more receptors in this family, and he sees a potential for developing therapies based on his team’s findings. “These molecules are expressed abnormally in a number of diseases, so the idea that you can control them is exciting. Perhaps we can develop an antibody or a small molecule that blocks their action and changes cellular function.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Gene Testing Now Allows Precision Medicine for Thoracic Aneurysms
Researchers at the Aortic Institute at Yale have tested the genomes of more than 100 patients with thoracic aortic aneurysms, a potentially lethal condition, and provided genetically personalized care.
Monday, July 20, 2015
After a Sip of Milkshake, Genes and Brain Activity Predict Weight Gain
The new study published in The Journal Neuroscience.
Thursday, May 21, 2015
A Faster, Less Expensive Way To Analyze Gene Activity
Yale researchers have devised a method that could reduce the time and cost of analyzing gene activity.
Tuesday, March 03, 2015
Single-Cell, 42-plexed Protein Analysis Achieved with a New Microchip Technology
A novel microdevice capable of detecting 42 unique immune effector proteins has been developed.
Tuesday, February 17, 2015
Yale Team Implants Human Innate Immune Cells in Mice
Groundbreaking study has reproduced human immune function at a level not seen previously.
Tuesday, March 18, 2014
Genetic Mutation Causes Lupus in Mice
Discovery could open the way for development of therapies that target the mutation.
Tuesday, January 07, 2014
Biomarkers Indicate Increased Risk of Death After Discharge from Cardiac Surgery
Following cardiac surgery, patients with elevated levels of kidney injury biomarkers are at a significantly higher risk of dying during the next three years, a Yale study has found.
Monday, December 23, 2013
Follow the Genes: Yale Team Finds Clues to Origin of Autism
A team of researchers has pinpointed which cell types and regions of the developing human brain are affected by gene mutations linked to autism.
Wednesday, November 27, 2013
Awakening Genes that Suppress Tumors
When genes that normally suppress tumor growth are themselves suppressed, cancer cells can grow and proliferate uncontrollably.
Tuesday, October 15, 2013
Alzheimer’s Missing Link Found: Is a Promising Target for New Drugs
Researchers have discovered a protein that is the missing link in the complicated chain of events that lead to Alzheimer’s disease.
Monday, September 09, 2013
Loss of Gene Expression may Trigger Cardiovascular Disease
A Yale-led team of researchers has uncovered a genetic malfunction that may lead to hardening of the arteries and other forms of cardiovascular disease.
Friday, November 30, 2012
Lessons from 1000 Genomes: Small Differences Matter
A newly published compendium of the genetic alphabets of more than 1000 individuals from around the world illustrates how similar humans are – but also how crucial genetic variations can be.
Thursday, November 01, 2012
Scientific News
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
New Way to Force Stem Cells to Become Bone Cells
Potential therapies based on this discovery could help people heal bone injuries or set hardware, such as replacement knees and hips.
Promise of Newborn Stem Cells to Revolutionize Clinical Practice
In this article Shweta Sharma, PhD, discusses the potential of an Umbilical Cord Blood bank as an untapped source of samples for research and clinical trials.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Coronavirus Breakthrough
Protein mutation affects spread and virulence of respiratory virus.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Circadian Clock Controls Insulin and Blood Sugar in Pancreas
Map of thousands of genes suggests new therapeutic targets for diabetes.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos